Literature DB >> 24529612

Prospective relationship between duration of untreated psychosis and 13-year clinical outcome: a first-episode psychosis study.

Jennifer Yee-Man Tang1, Wing-Chung Chang2, Christy Lai-Ming Hui2, Gloria Hoi-Yan Wong2, Sherry Kit-Wa Chan2, Edwin Ho-Ming Lee2, Wai-Song Yeung3, Chi-Keung Wong3, Wai-Nang Tang3, Wah-Fat Chan3, Edwin Pui-Fai Pang4, Steve Tso5, Roger Man-Kin Ng6, Se-Fong Hung7, Eva Lai-Wah Dunn3, Pak-Chung Sham8, Eric Yu-Hai Chen8.   

Abstract

BACKGROUND: The adverse effects of a long duration of untreated psychosis (DUP) have been explored in numerous short-term studies. These studies support the development of early interventions that reduce treatment delay and promote recovery. However, the enduring impact of DUP is largely unknown, partly due to the paucity of prospective long-term studies. Although the DUP-outcome relationship is commonly assumed to be linear, the threshold effect has not been adequately examined.
OBJECTIVE: To explore the relationship between DUP and long-term symptomatic remission.
METHODS: This was a prospective study of a cohort of 153 first-episode psychosis patients in Hong Kong at the 13-year follow-up. The patients were categorized into short (≤30days), medium (31-180days) and long (>180days) DUP groups.
RESULTS: The long-term outcome was ascertained in 73% of the patients. Nearly half of the patients (47%) fulfilled the criteria for symptomatic remission. The short DUP group experienced a significantly higher remission rate over the course of the illness. The odds of long-term symptomatic remission was significantly reduced in the medium DUP (by 89%) and long DUP (by 85%) groups compared with the short DUP group. Further analysis showed that DUP had a specific impact on negative symptom remission.
CONCLUSION: The findings support the threshold theory that DUP longer than 30days adversely impacts the long-term outcome. The present study is one of the few studies that confirmed the enduring impact of DUP on long-term outcomes based on well-defined criteria and adequate statistical adjustment.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Duration of untreated psychosis; Long-term outcome; Prospective study; Psychotic disorders; Remission; Risk factors

Mesh:

Substances:

Year:  2014        PMID: 24529612     DOI: 10.1016/j.schres.2014.01.022

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  19 in total

1.  Untreated illness and recovery in clients of an early psychosis intervention program: a 10-year prospective cohort study.

Authors:  Gina Bhullar; Ross M G Norman; Neil Klar; Kelly K Anderson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-11-29       Impact factor: 4.328

2.  Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia in 106,160 Patients Across Four Health Care Systems.

Authors:  Amanda B Zheutlin; Jessica Dennis; Richard Karlsson Linnér; Arden Moscati; Nicole Restrepo; Peter Straub; Douglas Ruderfer; Victor M Castro; Chia-Yen Chen; Tian Ge; Laura M Huckins; Alexander Charney; H Lester Kirchner; Eli A Stahl; Christopher F Chabris; Lea K Davis; Jordan W Smoller
Journal:  Am J Psychiatry       Date:  2019-08-16       Impact factor: 18.112

3.  Early-Stage Negative Symptom Trajectories and Relationships With 13-Year Outcomes in First-Episode Nonaffective Psychosis.

Authors:  Wing Chung Chang; Ryan Wui Hang Ho; Jennifer Yee Man Tang; Corine Sau Man Wong; Christy Lai Ming Hui; Sherry K W Chan; Edwin M H Lee; Yi Nam Suen; Eric Y H Chen
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306

Review 4.  What does schizophrenia teach us about antipsychotics?

Authors:  Gary Remington; Ofer Agid; George Foussias; Gagan Fervaha; Hiroyoshi Takeuchi; Jimmy Lee; Margaret Hahn
Journal:  Can J Psychiatry       Date:  2015-03       Impact factor: 4.356

5.  Cross-country variations in the reporting of psychotic symptoms among sub-Saharan African adults: A psychometric evaluation of the Psychosis Screening Questionnaire.

Authors:  Mary Bitta; Yanga Thungana; Hannah H Kim; Christy A Denckla; Amantia Ametaj; Mahlet Yared; Claire Kwagala; Linnet Ongeri; Rocky E Stroud; Edith Kwobah; Karestan C Koenen; Symon Kariuki; Zukiswa Zingela; Dickens Akena; Charles Newton; Lukoye Atwoli; Solomon Teferra; Dan J Stein; Bizu Gelaye
Journal:  J Affect Disord       Date:  2022-02-18       Impact factor: 6.533

6.  Family functioning moderates the impact of psychosis-risk symptoms on social and role functioning.

Authors:  Elizabeth Thompson; Pamela Rakhshan; Steven C Pitts; Caroline Demro; Zachary B Millman; Kristin Bussell; Jordan DeVylder; Emily Kline; Gloria M Reeves; Jason Schiffman
Journal:  Schizophr Res       Date:  2018-09-08       Impact factor: 4.939

7.  First episode of psychosis in a middle-aged patient with a 14-year history of conversion disorder.

Authors:  Vaios Peritogiannis; Thiresia Manthopoulou; Venetsanos Mavreas
Journal:  Case Rep Psychiatry       Date:  2014-12-18

8.  Reducing the duration of untreated psychosis and its impact in the U.S.: the STEP-ED study.

Authors:  Vinod H Srihari; Cenk Tek; Jessica Pollard; Suzannah Zimmet; Jane Keat; John D Cahill; Suat Kucukgoncu; Barbara C Walsh; Fangyong Li; Ralitza Gueorguieva; Nina Levine; Raquelle I Mesholam-Gately; Michelle Friedman-Yakoobian; Larry J Seidman; Matcheri S Keshavan; Thomas H McGlashan; Scott W Woods
Journal:  BMC Psychiatry       Date:  2014-12-04       Impact factor: 3.630

9.  Only a small proportion of patients with first episode psychosis come via prodromal services: a retrospective survey of a large UK mental health programme.

Authors:  Olesya Ajnakina; Craig Morgan; Charlotte Gayer-Anderson; Sherifat Oduola; François Bourque; Sally Bramley; Jessica Williamson; James H MacCabe; Paola Dazzan; Robin M Murray; Anthony S David
Journal:  BMC Psychiatry       Date:  2017-08-25       Impact factor: 3.630

10.  Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region.

Authors:  Tak Lam Lo; Matthew Warden; Yanling He; Tianmei Si; Seshadri Kalyanasundaram; Manickam Thirunavukarasu; Nurmiati Amir; Ahmad Hatim; Tomas Bautista; Cheng Lee; Robin Emsley; Jose Olivares; Yen Kuang Yang; Ronnachai Kongsakon; David Castle
Journal:  Asia Pac Psychiatry       Date:  2016-06       Impact factor: 2.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.